UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$188M |
| 2 |
Yelp
YELP
|
+$182M |
| 3 |
General Motors
GM
|
+$141M |
| 4 |
American Express
AXP
|
+$138M |
| 5 |
Comcast
CMCSA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$331M |
| 2 |
Crown Castle
CCI
|
+$303M |
| 3 |
Cardinal Health
CAH
|
+$204M |
| 4 |
Gilead Sciences
GILD
|
+$157M |
| 5 |
Apple
AAPL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Healthcare | 13.9% |
| 3 | Technology | 13.4% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
CSX Corp
CSX
$93B
| $88M | 0.1% |
9,179,076
+258,096
| +3% | +$2.31M |
|
|
SCHW
227
Charles Schwab
SCHW
$181B
| $87.8M | 0.1% |
3,376,485
+140,540
| +4% | +$3.35M |
|
|
SE
228
DELISTED
Spectra Energy Corp Wi
SE
| $87.3M | 0.1% |
2,451,146
+144,718
| +6% | +$4.98M |
|
229
Lumen
LUMN
$6.76B
| $86.4M | 0.1% |
2,713,925
+394,438
| +17% | +$12.6M |
|
|
HSP
230
DELISTED
HOSPIRA INC
HSP
| $85.8M | 0.1% |
2,078,583
-503,156
| -19% | -$20.3M |
|
231
Allstate
ALL
$68.3B
| $85.8M | 0.1% |
1,572,311
+7,663
| +0.5% | +$409K |
|
|
APOL
232
DELISTED
Apollo Education Group Inc Class A
APOL
| $85.1M | 0.1% |
3,115,763
-179,450
| -5% | -$4.46M |
|
233
Welltower
WELL
$170B
| $85M | 0.1% |
1,586,812
+169,941
| +12% | +$10.1M |
|
|
MRO
234
DELISTED
Marathon Oil Corporation
MRO
| $85M | 0.1% |
2,407,280
+57,107
| +2% | +$2.04M |
|
235
Healthpeak Properties
DOC
$15.2B
| $84.9M | 0.1% |
2,565,944
+184,975
| +8% | +$6.6M |
|
236
Enbridge
ENB
$121B
| $84.7M | 0.1% |
1,939,453
+68,594
| +4% | +$2.89M |
|
237
Ventas
VTR
$44.7B
| $83.4M | 0.1% |
1,275,680
+51,450
| +4% | +$3.57M |
|
238
Cooper Companies
COO
$14.2B
| $83.2M | 0.1% |
2,687,772
+507,332
| +23% | +$16.2M |
|
|
AET
239
DELISTED
Aetna Inc
AET
| $83M | 0.09% |
1,210,031
-167,399
| -12% | -$10.9M |
|
240
Truist Financial
TFC
$63.5B
| $81.9M | 0.09% |
2,194,904
+93,974
| +4% | +$3.25M |
|
241
Devon Energy
DVN
$50.9B
| $81.8M | 0.09% |
1,321,369
+45,731
| +4% | +$2.8M |
|
|
XLNX
242
DELISTED
Xilinx Inc
XLNX
| $81.1M | 0.09% |
1,765,496
+951
| +0.1% | +$42.8K |
|
243
Sysco
SYY
$40.6B
| $80.5M | 0.09% |
2,230,843
+217,701
| +11% | +$7.36M |
|
244
Zoetis
ZTS
$31.9B
| $79.6M | 0.09% |
2,434,159
-240,404
| -9% | -$7.67M |
|
245
Williams Companies
WMB
$86.7B
| $79.2M | 0.09% |
2,054,344
+79,302
| +4% | +$2.85M |
|
246
Corning
GLW
$116B
| $78.9M | 0.09% |
4,426,060
+107,953
| +3% | +$1.78M |
|
247
Verisk Analytics
VRSK
$26.1B
| $78.8M | 0.09% |
1,199,302
+649,180
| +118% | +$42.6M |
|
248
Bio-Rad Laboratories Class A
BIO
$8.74B
| $78.4M | 0.09% |
634,397
+69,735
| +12% | +$8.5M |
|
|
ACOR
249
DELISTED
Acorda Therapeutics
ACOR
| $77.8M | 0.09% |
22,201
+1,539
| +7% | +$6M |
|
250
Vornado Realty Trust
VNO
$7.55B
| $77.6M | 0.09% |
1,195,046
+52,717
| +5% | +$3.41M |
|
Similar funds
UBS AM's Q4 2013 Portfolio in Review
As of Q4 2013, UBS AM held 2,637 positions worth $87.5B, up 8.1% from $80.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2013 filing shows 130 new, 1,010 increased, 1,128 reduced and 103 closed positions. Its largest new stake was Trip.com Group: 2,309,000 shares worth $57.3M. The largest sale was eBay, an estimated $331M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- UBS AM's largest Q4 2013 buy was Trip.com Group: 2,309,000 shares worth $57.3M.
- UBS AM added most to Regeneron Pharmaceuticals in Q4 2013, an estimated $188M increase.
- UBS AM's biggest Q4 2013 reduction was eBay, cutting an estimated $331M.
- UBS AM fully exited DELL INC in Q4 2013, selling an estimated $62.9M.
- UBS AM's ten largest holdings make up 14% of its $87.5B portfolio in Q4 2013.
- UBS AM opened 130 new positions and closed 103 in Q4 2013.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $87.5B.
Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.